Ziqi Zhou

发表

OTT_A_229577 185..197

J. Xia, Yan Tang, Xu-Qiong Huang, 2020 .

Cancer‐Associated Fibroblast‐Mediated Cellular Crosstalk Supports Hepatocellular Carcinoma Progression

Yaojun Zhang, Jing-jing Zhao, Qi-jing Wang, 2021, Hepatology.

Safety and activity of PD-1 blockade-activated DC-CIK cells in patients with advanced solid tumors

F. Zhou, Zhi‐Ling Zhang, Chuan-miao Xie, 2017, Oncoimmunology.

Tripartite motif-containing 3 (TRIM3) inhibits tumor growth and metastasis of liver cancer

Jing-jing Zhao, Qiu-zhong Pan, J. Xia, 2017, Chinese journal of cancer.

The efﬁcacy and safety of the combination of axitinib and pembrolizumab-activated autologous DC-CIK cell immunotherapy for patients with advanced renal cell carcinoma: a phase 2 study

Yan Ding, Jing-jing Zhao, Qi-jing Wang, 2021 .

Clinical Effect of Adjuvant Cytokine-Induced Killer Cells Immunotherapy in Patients with Stage II-IVB Nasopharyngeal Carcinoma after Chemoradiotherapy: A propensity score analysis

Jing-jing Zhao, Qiu-zhong Pan, J. Xia, 2018, Journal of Cancer.

CMAR_A_200627 6691..6702

Jing-jing Zhao, Qiu-zhong Pan, J. Xia, 2019 .

Pooled safety analyses of ALK-TKI inhibitor in ALK-positive NSCLC

J. Xia, Yan Tang, D. Weng, 2017, BMC Cancer.

Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma

Min Li, J. Xia, Chao Yang, 2020, Journal of Hematology & Oncology.

Overexpression of SMOC2 Attenuates the Tumorigenicity of Hepatocellular Carcinoma Cells and Is Associated With a Positive Postoperative Prognosis in Human Hepatocellular Carcinoma

J. Xia, Yan Tang, Jian-hua Zhang, 2017, Journal of Cancer.

Overexpression of SMOC 2 Attenuates the Tumorigenicity of Hepatocellular Carcinoma Cells and Is Associated With a Positive Postoperative Prognosis in Human Hepatocellular Carcinoma

J. Xia, Yan Tang, Jian-hua Zhang, 2017 .

Decreased TPD52 expression is associated with poor prognosis in primary hepatocellular carcinoma

Shan-shan Jiang, J. Xia, Ying Wu, 2015, Oncotarget.

Galectin-3 favours tumour metastasis via the activation of β-catenin signalling in hepatocellular carcinoma

J. Xia, Yan Tang, D. Weng, 2020, British Journal of Cancer.

Protein kinase CK2α catalytic subunit is overexpressed and serves as an unfavorable prognostic marker in primary hepatocellular carcinoma

Shan-shan Jiang, J. Xia, Yan Tang, 2015, Oncotarget.

Large-scale analyses identify a cluster of novel long noncoding RNAs as potential competitive endogenous RNAs in progression of hepatocellular carcinoma

J. Xia, Yan Tang, D. Weng, 2019, Aging.

Dendritic‐cell‐based immunotherapy evokes potent anti‐tumor immune responses in CD105+ human renal cancer stem cells

A. Chang, M. Wicha, Y. Zeng, 2017, Molecular carcinogenesis.

The efficacy and safety of the combination of axitinib and pembrolizumab‐activated autologous DC‐CIK cell immunotherapy for patients with advanced renal cell carcinoma: a phase 2 study

F. Zhou, J. Xia, P. Dong, 2021, Clinical & translational immunology.

IL-17 induces antitumor immunity by promoting beneficial neutrophil recruitment and activation in esophageal squamous cell carcinoma

Chun-yu Huang, J. Xia, Yan Tang, 2018, Oncoimmunology.

Bromodomain-containing protein 7 (BRD7) as a potential tumor suppressor in hepatocellular carcinoma

K. Pan, Shan-shan Jiang, J. Xia, 2016, Oncotarget.

PD-L1 expression as a predictive biomarker for cytokine-induced killer cell immunotherapy in patients with hepatocellular carcinoma

Y. Zeng, K. Pan, Shan-shan Jiang, 2016, Oncoimmunology.

Orchestration of immune checkpoints in tumor immune contexture and their prognostic significance in esophageal squamous cell carcinoma

J. Xia, Peng Wang, Yan Tang, 2018, Cancer management and research.

Screening and identification of hub genes in bladder cancer by bioinformatics analysis and KIF11 is a potential prognostic biomarker

J. Xia, Jiezhi Yang, D. Weng, 2021, Oncology letters.

The Roles of Ubiquitination Factor E4B (UBE4B) in the Postoperative Prognosis of Patients with Renal Cell Carcinoma and in Renal Tumor Cells Growth and Metastasis

J. Xia, Yan Tang, Jian-hua Zhang, 2020, OncoTargets and therapy.

Weekly versus triweekly cisplatin plus intensity-modulated radiotherapy in locally advanced nasopharyngeal carcinoma: A propensity score analysis with a large cohort

J. Xia, R. You, Yan Tang, 2018, Journal of Cancer.

PD-L1 expression is a predictive biomarker for CIK cell-based immunotherapy in postoperative patients with breast cancer

J. Xia, Yan Tang, D. Weng, 2019, Journal of Immunotherapy for Cancer.

The clinical significance of preoperative serum cholesterol and high-density lipoprotein-cholesterol levels in hepatocellular carcinoma

Minshan Chen, Yaojun Zhang, K. Pan, 2016, Journal of Cancer.

Pooled safety analyses of ALK-TKI inhibitor in ALK-positive NSCLC

J. Xia, Yan Tang, D. Weng, 2017, BMC Cancer.

IL-37 induces anti-tumor immunity by indirectly promoting dendritic cell recruitment and activation in hepatocellular carcinoma

J. Xia, Yan Tang, D. Weng, 2019, Cancer management and research.

The Roles of Ubiquitination Factor E4B (UBE4B) in the Postoperative Prognosis of Patients with Renal Cell Carcinoma and in Renal Tumor Cells Growth and Metastasis

J. Xia, Yan Tang, Jian-hua Zhang, 2020 .

Reduced expression of Rap1GAP as a prognostic biomarker for primary gastric cancer patients.

Peng Wang, D. Weng, Cong Mai, 2018, Cancer biomarkers : section A of Disease markers.

HUS1 checkpoint clamp component (HUS1) is a potential tumor suppressor in primary hepatocellular carcinoma

J. Xia, Yan Tang, D. Weng, 2018, Molecular carcinogenesis.